Importance Health care–associated infections (HAIs) account for a large proportion of the
harms caused by health care and are associated with high costs. Better evaluation of the …

Background Clostridium difficile is a leading cause of morbidity and mortality in several
countries. However, there are limited evidence characterizing its role as a global public …

BACKGROUND & AIMS: Gastrointestinal (GI) diseases account for substantial morbidity,
mortality, and cost. Statistical analyses of the most recent data are necessary to guide GI …

Clostridium difficile infection is increasing in incidence, severity, and mortality. Treatment
options are limited and appear to be losing efficacy. Recurrent disease is especially …

OBJECTIVES: While fecal microbiota transplantation (FMT) is historically known to be an
effective means to treat recurrentClostridium difficileinfection (CDI) refractory to standard …

Fecal microbiota transplantation (FMT) has been utilized sporadically for over 50 years. In
the past few years, Clostridium difficile infection (CDI) epidemics in the USA and Europe …

OBJECTIVES: Clostridium difficileinfection (CDI) is a common hospital-acquired infection
with increasing incidence, severity, recurrence, and associated morbidity and mortality …

The epidemiology of Clostridium difficile infection (CDI) has changed dramatically during
this millennium. Infection rates have increased markedly in most countries with detailed …

Clostridioides difficile Infection (Japanese Version) Page 1 Annals of Internal Medicine® In
the Clinic® Clostridioides difficile 感染症 Clostridioides difficile (以前はClostridium difficileと …

A common complication of antibiotic use is the development of gastrointestinal disease. This
complication ranges from mild diarrhea to pseudomembranous colitis. Outbreaks of …